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Abstract 
Background: In the recent years natural resources are being in focus due to their great 
potential to be exploited in the discovery/development of novel bioactive compounds and, 
among them, mushrooms can be highlighted as alternative sources of anti-inflammatory 
agents.  
Scope and approach: The present review reports the anti-inflammatory activity of 
mushroom extracts and of their bioactive metabolites involved in this bioactive action. 
Additionally the most common assays used to evaluate mushrooms anti-inflammatory 
activity were also reviewed, including in vitro studies in cell lines, as well as in animal 
models in vivo. 
Key findings and conclusions: The anti-inflammatory compounds identified in mushrooms 
include polysaccharides, terpenes, phenolic acids, steroids, fatty acids and other metabolites. 
Among them, polysaccharides, terpenoids and phenolic compounds seem to be the most 
important contributors to the anti-inflammatory activity of mushrooms as demonstrated by 
numerous studies. However, clinical trials need to be conducted in order to confirm the 
effectiveness of some of these mushroom compounds namely, inhibitors of NF-κB pathway 
and of cyclooxygenase related with the expression of many inflammatory mediators. 
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1. Introduction 
Inflammation is a physiological response to injury, characterised by loss of function and pain, 
heat, redness and swelling. It is usually associated with the pathogenesis of diseases such as 
diabetes, arthritis, obesity, metabolic syndrome, cancer and several cardiovascular diseases 
(Bellik et al., 2012; Moro et al., 2012; Ma, Chen, Dong, & Lu, 2013). 
An immune stimulant causes the pro-inflammatory cells, such as macrophages and 
monocytes, to start to secrete a number of inflammatory mediators such as interleukins (IL 
1β, IL-6, IL-8), tumor necrosis factor (TNF-α), nuclear factor-κB (NF-κB), intercellular 
adhesion molecule-1 (ICAM- 1), inducible type cyclooxygenase-2 (COX-2), prostaglandin 
E2 (PGE2), 5-lipoxygenase (5-LOX), and inducible nitric oxide synthase (iNOS) (Moro et 
al., 2012; Choi et al., 2014a; Taofiq et al., 2015). Uncontrolled production of these 
inflammatory mediators has been known to cause several cell damage and also initiate the 
inflammation process (Kanwar, Kanwar, Burrow, & Baratchi, 2009). 
Natural products are good resources for development of therapeutic compounds with anti-
inflammatory potential and without or lower toxic effects (Yuan, Wahlqvist, He, & Yang, 
2006). Several bioactive compounds from plants (Wang et al., 2013c), rhizomes (Debnath et 
al., 2013) and marine algae (Kim et al., 2014) have been isolated and their anti-inflammatory 
effect studied by various mechanisms. 
Mushrooms are nutritionally functional foods that have been an integral part of our diet for 
years. They have not just been consumed for their culinary importance because of their 
unique taste and flavour (Kalač, 2013), but also because of their potential therapeutic 
properties which dates back to over 2000 years ago and are recognized as effective to treat 
and prevent varieties of disorders (Lim et al., 2007; Moro et al., 2012; Silveira et al., 2014). 
Presently they are significantly consumed in western countries (Lindequist, Niedermeyer, & 
Julich, 2005). The main commercial mushrooms are Agaricus bisporus L., Lentinus edodes	
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(Berk.) Pegler and Pleurotus ostreatus (Jacq. ex Fr.) P. Kumm, known to be a vital source of 
proteins, carbohydrates, minerals and vitamins (Dore et al., 2007). Mushrooms (fruiting 
bodies, mycelia or their submerged fermentation broth) are rich in several bioactive 
compounds, either if wild, edible or cultivated species (Alves et al., 2013b). These bioactive 
metabolites include phenolic compounds, terpenoids, polysaccharides, lectins, steroids, 
glycoproteins and several lipid components ((Reis, Barros, Martins, & Ferreira, 2012)). 
Several studies have been conducted to evidence the bioactive properties of mushroom 
extracts as well as of their secondary metabolites such as antioxidant (Ferreira, Barros, & 
Abreu, 2009; Heleno, Martins, Queiroz, & Ferreira, 2015; Puttaraju, Venkateshaiah, 
Dharmesh, Urs, &Somasundaram, 2006), antitumor (Carocho & Ferreira, 2013; Ferreira, 
Vaz, Vasconcelos, & Martins, 2010; Moradali, Mostafavi, Ghods, & Hedjaroude, 2007), 
antimicrobial (Alves et al., 2012, 2013a), immunomodulator (Borchers, Krishnamurthy, 
Keen, Meyers, & Gershwin, 2008), antiatherogenic (Mori, Kobayashi, Tomita, Inatomi, & 
Ikeda, 2008) hypoglycemic (Hu, Wang, Lien, Liaw, & Lee, 2006) and anti-inflammatory 
(Moro et al., 2012; Tung et al., 2013; Han et al., 2013; Xu et al., 2013; Choi et al., 2014a; 
Taofiq et al., 2015) activities. 
Most research studies conducted on the pharmacological potential of mushrooms are mainly 
focused on crude extracts. Nevertheless, it is also important to identify the bioactive 
compounds responsible for each one of the ascribed bioactivities. In this context, the anti-
inflammatory activity of several mushroom species has been reported as well as of their 
bioactive metabolites. It has been related with a reduction in the production of nitric oxide 
(NO) and other inflammatory mediators such as interleukins (IL 1β, IL-6, IL-8), tumor 
necrosis factor (TNF-α) and prostaglandin E2 (PGE2), causing reduction of inflammation 
(Jedinak, Dudhgaonkar, Wu, Simon, & Sliva, 2011; Moro et al., 2012; Fangkrathok, Junlatat, 
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& Sripanidkulchai, 2013; Choi et al., 2014a; Lee et al., 2014; Gunawardena et al., 2014; 
Taofiq et al., 2015).  
 
2. Inflammatory mediators and cell signalling  
Inflammation is one of most important biological responses to remove harmful toxins or 
pathogens from the body (Jung et al., 2013). During inflammation, macrophages, monocytes 
and other inflammatory cells secrete excess inflammatory mediators, among them NO. 
Macrophages are the first line of defence against invading pathogens. They are large 
specialized cells that engulf and digest cellular debris, microbes, and cancer cells in a process 
called phagocytosis. They play important roles in non-specific host defence mechanism and 
help to initiate other defence mechanisms. Beyond stimulating the immune system, 
macrophages play a crucial role in the inflammatory response through the release of a variety 
of factors. Production of these mediators in inflammatory cells increases following exposure 
to immune stimulants including bacterial endotoxin lipopolysaccharide (LPS) or viral 
proteins (Hseu et al., 2005). This bacteria component initiates several signal transduction 
pathways that are central to the pathogenesis of inflammation (Jeong et al., 2010).  
NO is a short-lived free radical and a signalling molecule produced from L-arginine by the 
inducible nitric oxide synthase (iNOS) enzyme (Hämäläinen, Nieminen, Vuorela, Heinonen, 
& Moilanen, 2007; Castro et al., 2014). NO, known to induce vasodilation in the 
cardiovascular system through a Ca2+-dependent pathway, play an important function in the 
immune and nervous systems as well as in cell death (Hseu et al., 2005; Sharma, Al-Omran, 
& Parvathy, 2007). It gives an anti-inflammatory effect under normal physiological 
conditions, being also involved in many pathological diseases in the body (Cirino, Distrutti, 
& Wallace, 2006; Joo et al., 2014).  
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Reactive oxygen species (ROS) production play an important role in the modulation of 
inflammation. Major ROS produced within the cell are superoxide anion (O2-), hydrogen 
peroxide (H2O2), peroxide anion (O22-), hydroxyl ion (OH-) and hydroxyl radical (OH˙). 
Nitric oxide is less reactive but has the ability to attack superoxide ion (O2-) to form 
peroxynitrite ONOO- (Castro et al., 2014). This peroxynitrite and several oxidative products 
can accumulate in the cells causing several oxidative damages and increased cytotoxicity 
leading to tumor development, DNA damage and cell proliferation (Quang, Harinantenaina, 
Nishizawa, Hashimoto, Kohchi, Soma, & Asakawa, 2006a; Fangkrathok, Junlatat, & 
Sripanidkulchai, 2013). The inhibition of NO and other inflammatory mediators 
overproduction in cells may prevent the occurrence of inflammatory diseases and cancer 
(Cirino et al., 2006; Sharma, Al-Omran, & Parvathy, 2007).  
Another class of important pro-inflammatory mediator is the tumor necrosis factor-α (TNF-α) 
secreted by activated macrophages, T-lymphocytes, mast cells, natural killer cells, monocytes 
and other defence cells (Habtemariam, 2013). Tumor necrosis factor-α (TNF-α) is one of the 
important pro-inflammatory mediators involved in the inflammatory process. When there is 
an immune stimulant, TNF-α attaches to some specific transmembrane receptors that tend to 
activate several signal transduction pathways responsible for production of more and more 
TNF-α to the site of infection (Bradley, 2008). As TNF-α continues to accumulate, it causes a 
wide range of human diseases, apoptosis, excess pain and cell damage. Regulation of the 
transcription factor NF-κB is the key component of TNF-α regulation (Habtemariam, 2013). 
The inhibition of TNF-α in LPS activated THP-1 monocytic cells, or RAW 264.7 
macrophage cells, is generally used as in vitro model for evaluating the anti- inflammatory 
effects of various materials including mushroom extracts (Wu, Lu, Lai, & Ng, 2013a). Some 
of the studied mushrooms whose mechanism of action is the inhibition of TNF-α release are 
shown in Table 1. 
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NF-κB is a transcription factor that regulates the expression of several pro-inflammatory 
cytokines and enzymes such as IL-1β, TNF-α, iNOS, and COX-2 that play vital roles in 
apoptosis, in the immune system, as well as in the inflammation (Hseu, Huang, & Hsiang,  
2010). When there is an immune stimulant such as lipopolysaccharide, viral proteins or 
cytokines, the NF-κB becomes activated (Kim et al., 2003). Toll like receptors (TLRs) and 
tumor necrosis factor receptor (TNFr) localised in the macrophages membrane have the 
ability to detect these pathogen-associated microbial patterns (PAMPs) necessary for 
activation of several signalling cascade (Figure 1). After ligand binding, these receptors 
activate the myeloid differentiation protein 88 (MyD88) responsible for activation of mitogen 
activated protein kinase (MAPKs). This MAPKs further activate the IKK kinases (IKKα, 
IKKβ, IKKγ) leading to phosphorylation of IkB proteins complex (Hasnat, Pervin, Cha, Kim, 
& Lim, 2015). Cytosolic IKB forms a complex with NF-κB and the IkB proteins becomes 
degraded allowing NF-κB to translocate to the nucleus where it triggers the transcription of 
several chemokine and cytokine genes involved in the innate and adaptive immune response 
(Kim et al., 2003). Some polyphenols have been known to inhibit specific steps in the 
pathway leading to NF-κB release (Ruiz & Haller, 2006). These authors investigated the anti-
inflammatory mechanisms of flavonoids that were able to inhibit the phosphorylation of IkB 
preventing translocation of NF-kB to the nucleus. Hence, finding natural inhibitors of NF-kB 
for treatment and prevention of various inflammatory diseases have been the target of several 
scientists (Kim et al., 2003). 
 
3. NSAIDs and their mechanism of action 
The nonsteroidal anti-inflammatory drugs (NSAIDs) are a group of medications commonly 
administered to manage pain and inflammation (Moro et al., 2012). Most of them are 
available over the counter in the United States while the rest needs prescription (Meek, van 
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de Laar, & Vonkeman, 2010). Several side effects have been associated with frequent 
administration of NSAIDs particularly in the gastrointestinal (GI) tract where they cause 
bleeding, intestinal perforation and peptic ulcer (Dugowson & Gnanashanmugam, 2006). 
Other less pronounce side effects include renal dysfunction, high blood pressure and 
cardiovascular toxicity (Elsayed, Hesham, Mohammad, & Aziz, 2014). NSAIDs act by 
inhibiting the intracellular cyclo-oxygenase enzymes which has two isoforms (COX-1 and 
COX-2). Cyclooxygenase are enzymes involved in the process of inflammation (Noreen, 
Ringbom, Perera, Danielson, & Bohlin, 1998). They catalyse the rate-limiting step in the 
biosynthesis of prostaglandins, prostacyclins, and thromboxanes from arachidonic acid 
(Zhang, Mills, & Nair, 2003; Diyabalanage, Mulabagal, Mills, DeWitt, & Nair, 2008; 
Stanikunaite, Khan, Trappe, & Ross, 2009; Han, Oh, & Park, 2011; Fangkrathok, Junlatat, & 
Sripanidkulchai, 2013).		
Prostaglandins (PG) are hormone-like chemicals in the body that perform ‘‘housekeeping’’ 
functions required for normal physiological activities. They are structurally related and have 
regulatory roles as well as pathological implication (Silveira et al., 2014). Cyclooxygenase 
enzymes catalyzes the conversion of arachidonic acid to PGH2, which is converted to other 
prostanoid species including PGD2, PGE2, prostacyclin (PGI2), and thromboxane (TXA2) by 
the action of specific synthases (Figure 2) (Joo & Sadikot, 2012). COX-1 is primarily 
involved in the regulation of homeostatic functions and is constitutively expressed in a wide 
variety of cells, promoting physiological functions, such as gastric mucosal protection, 
control of renal blood flow, hemostasis, autoimmune responses, lungs, central nervous 
system, cardiovascular system and reproductive functions (Grosser, Fries, & Fitzgerald, 
2006).  
On the other hand, COX-2 is an inducible isoform of prostaglandin synthase in activated 
macrophages, fibroblasts, and endothelial cells that are responsible for inflammation. They 
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are expressed significantly due to stimuli such as cytokines, endotoxins, viral proteins and 
growth factors. COX-2 originates inducing prostaglandins, which contributes to the 
development of the four cardinal signs of inflammation: pain, heat, redness and swelling, thus 
being considered as the main target for the anti-inflammatory action (Fitzgerald, 2004). 
The search for selective inhibitors of COX-2 is considered important, on the basis of the 
theory that the side effects, such as gastric lesions, that occurred from inhibition of COX-1 
activity, were observed with some non-selective nonsteroidal anti-inflammatory drugs 
(NSAIDs) (Supplementary material S1) such as dexamethasone, diclofenac and 
indomethacin (Lu et al., 2013). Until now, very few compounds of natural origin have been 
reported to possess COX-2 inhibitory effects. Yoshikawa et al. (2005) were the first to report 
the potential of lanostane triterpenoids and their glycosides as selective inhibitors of COX-2 
enzyme. 
Usually, NSAIDs inhibit both isoforms of the cyclooxygenase enzyme but the recently 
discovered selective COX-2 inhibitors (Supplementary material S2) are specific for the 
COX-2 isoform, thus exerting the anti-inflammatory property of COX-2 inhibition while 
theoretically evading the adverse effect associated with COX-1 isoform inhibition (Nowak, 
2012). Considerable resources have thus been invested in the pharmaceutical industries for 
development and design of drugs that act through selective inhibition of COX-2 to control 
inflammation with improved tolerability, less adverse effects, and without affecting normal 
metabolic processes (Shukla, Bafna, Sundar, & Thorat, 2014).     
 
4. Methodologies for anti-inflammatory activity screening 
4.1. In vitro assays 
4.1.1. Nitric oxide assay. The Griess reaction is a simple technique that is widely used for 
quantification/detection of NO. It was discovered by Johann Peter Griess (1829–1888), a 
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German organic chemist. The basic reaction involves reacting sulphaniliamide and N-(1-
naphthyl) ethylenediamine (NED) to form a stable azo compound. The absorbance of this 
compound at 540 nm is directly proportional to the nitrite concentration in the sample. 
Several in vitro measurement of NO production in LPS stimulated RAW 264.7 cells have 
been reported by several authors in the past, and this is one of the possible ways to screen 
various extracts and bioactive compounds with potential anti-inflammatory properties. RAW 
264.7 cells are seeded in 96-well plates, they are then treated with different concentrations of 
the sample to be studied followed by stimulation with LPS. The cell culture supernatant is 
then transferred to a new plate followed by addition of sulphanilamide and NED solutions. 
The NO produced is determined by measuring the absorbance at 540 nm. This assay is one of 
the most common and widely used for evaluation of anti-inflammatory activity as reported by 
different authors (Moro et al., 2012; Taofiq et al., 2015). 
 
4.1.2. Cytokine enzyme linked immunosorbent assay (ELISA). The enzyme linked 
immunosorbent assay (ELISA) is used for the detection and quantification of proteins 
typically secreted or released from cells. This method is usually used for quantification of 
cytokines and other inflammatory mediators such as interleukin (IL-1β, IL-6, IL-8) and 
tumour necrosis factor (TNF-α), as reported in a number of publications	 (Jedinak, 
Dudhgaonkar, Wu, Simon, & Sliva, 2011; Fangkrathok, Junlatat, & Sripanidkulchai, 2013; 
Lee et al., 2014; Gunawardena et al., 2014).	RAW 264.7 cells are usually plated in a 24-well 
plate in the culture medium, and then incubated with the sample to be screened at different 
concentrations. Cell culture supernatants are finally collected and assayed according to the 
instructions of the ELISA kit manufacturer (e.g., BD Pharmingen, San Diego CA, USA; 
DuoSet, R&D Systems, UK; MAX TM Set (Deluxe); BioLegend, San Diego, CA, USA) to 
determine the amount of TNF-α and IL-6 released from the cells.  
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4.1.3. COX-1 and COX-2 catalyzed prostaglandin biosynthesis assay 
The cyclooxygenase enzymes have been extensively used to study the anti-inflammatory 
potential of natural agents. This is not a very common method for anti-inflammatory activity 
assessment, but it has been reported in some publications (Noreen, Ringbom, Perera, 
Danielson, & Bohlin, 1998; Zhang et al., 2003; Yoshikawa et al., 2005; Stanikunaite, Khan, 
Trappe, & Ross, 2009). COX activity is usually determined based on the conversion of 
arachidonic acid to PGE2 and is expressed as a percentage of the control. RAW 264.7 cells 
are seeded in 96-well plates and incubated, being then stimulated with LPS to induce the 
production of COX-2 and other inflammatory mediators. Induced cells are treated with 
different concentrations of the samples. Arachidonic acid is added and the cells are further 
incubated. The amount of PGE2 released in the medium can be determined with PGE2 
enzyme immunoassay kit (Cayman Chem. Co. Michigan, USA).  
 
4.2. In vivo assays 
A lot of studies have reported in vivo anti-inflammatory activity of natural products achieved 
by inducing inflammation in mouse and measuring the degree of swelling relative to a 
positive control. In these animal models there is capillary dilation, increase blood vessel 
permeability, and edema similar to the ones associated with human acute inflammation 
(Wang et al., 2013a). The carrageenan-induced hind paw edema model has been used in a lot 
of research studies (Jose, Ajith, & Jananrdhanan, 2004; Deng et al., 2013; Lee et al., 2014). 
The methodology involves treating animals with extract at different concentration and also a 
control group with indomethacin, dexamethasone or any other non-steroidal anti-
inflammatory drug. This is followed by injection of hind paw with carrageenan in saline 
solution and by measuring the paw volume increment immediately and at different time 
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intervals (Lu et al., 2008). The degree of swelling induced by the injection is evaluated and 
the result compared with the control. Inflammation can also be induced by topical application 
of xylene in the ear of the mouse. After few minutes, the difference in swelling (Lu et al., 
2008) is estimated. Other in vivo anti-inflammatory assay induce inflammation, either by the 
croton oil-induced ear edema test (Kim et al., 2004; Won & Park, 2005; Dore et al., 2007) or 
by TPA, 12-O-tetradecanoylphorbol-13-acetate induced inflammation in mice, and sacrificed 
by cervical dislocation, to take punch biopsies to weight (Kamo, Asanoma, Shibata, & Hirota, 
2003; Dore et al., 2007; Liu et al., 2007). 
 
5. Mushroom metabolites with reported anti-inflammatory activity 
5.1. The anti-inflammatory potential of mushroom extracts 
Numerous investigations have suggested that several mushroom species can exhibit anti-
inflammatory potential based on their ability to reduce the production of inflammatory 
mediators (Kim et al., 2003; Padilha et al., 2009; Wen et al., 2011; Elsayed, Hesham, 
Mohammad, & Aziz, 2014 Taofiq et al., 2015). Their crude extracts (Table 1) have been 
described to display activity, and attention is now being focused on efforts to discover 
bioactive compounds capable to suppress the production of inflammatory mediators through 
gene expression downregulation of different types of inflammatory mediators (Kim et al., 
2006, Fangkrathok, Junlatat, & Sripanidkulchai, 2013). Previous research studies have been 
carried out on several mushroom species, mainly in methanolic (Kim et al., 2003; Wen et al., 
2011; Moro et al., 2012) and ethanolic (Won & Park, 2005; Kim et al., 2006; Ruthes et al., 
2013b; Taofiq et al., 2015) extracts. Most studies have shown that these extracts display anti-
inflammatory activity, but it is also crucial to identify the metabolites responsible for this 
bioactivity.  
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Different compounds have been isolated from mushrooms and implicated as responsible for 
the anti-inflammatory activity, e.g. polysaccharides (Dore, et al., 2007; Lu, et al., 2008; Lavi, 
Levinson, Peri, Hadar, & Schwartz, 2010; Adebayo, Oloke, Majolagbe, Ajani, & Bora, 2012; 
Ruthes, et al., 2013a, 2013b, 2013c; Chang, Lur, Lu, & Cheng, 2013; Castro et al., 2014; 
Silveira et al., 2014; Silveira et al., 2015), terpenes (Kamo, Asanoma, Shibata, & Hirota, 
2003; Yoshikawa et al., 2005; Dudhgaonkar, Thyagarajan, &  Sliva, 2009; Han et al., 2013; 
Ma, Chen, Dong, & Lu, 2013; Tung et al., 2013; Xu, Yan, Bi, Han, Chen, & Wu, 2013; Choi, 
et al., 2014a), phenolic compounds (Quang,  Harinantenaina, Nishizawa, Hashimoto, Kohchi, 
Soma, & Asakawa, 2006a; Quang et al., 2006b  Kohno et al., 2008; Stanikunaite, Khan, 
Trappe, & Ross, 2009; Hsieh et al., 2010; Lee, & Huang et al., 2011b; Chen et al., 2013; 
Taofiq et al., 2015), sterols (Huang, et al., 2010;	Ma, Chen, Dong, & Lu, 2013; Li, Zhou, Lee, 
Shim, Kim, & Kim, 2014b), fatty acids (Zhang, Mills, & Nair, 2003; Han & Cui, 2012), 
polysaccharide – protein complexes (Chen, Gonzalez de Mejia, & Wu, 2011; Zhou, Chen, 
Ding, Yao, & Gao, 2014) and other bioactive metabolites (Chien, Chen, Kuo, Tsai, Lin, & 
Kuo, 2008; Jeong et al., 2010). The anti-inflammatory properties of mushrooms have 
interested many scientists and motivated the study of several species (Table 1). 
Antrodia camphorata (M.Zang & C.H.Su) Sheng H.Wu, Ryvarden & T.T.Chang also known 
as “Taiwanofungus camphoratus” is a well-known medicinal mushroom with a lot of 
pharmacological potential. It has been reported to have antioxidant, hepatoprotective, anti-
inflammatory and immunomodulatory properties	(Geethangili & Tzeng, 2011). Hseu, Huang, 
& Hsiang (2010) reported the anti-inflammatory effect of fermented culture broth of A. 
camphorata by measuring the level of pro-inflammatory cytokine IL-1β and TNF-α 
expression in different organs using ELISA kits.  The extract was found to inhibit the LPS-
induced production of cytokines and also to suppress LPS-induced NF-kB activation in 
transgenic mice. The same researchers also studied fermentation culture of A. camphorata 
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and examined its effect in LPS stimulated RAW 264.7 cells for NO, PGE2, iNOS and COX-2 
protein expression. The results indicate that A. camphorata inhibit the production of TNF-α 
and IL-1β, NO and PGE2, as well as iNOS and COX-2 expression by blocking activation of 
NF-κB transcription factor. 
Gunawardena et al. (2014) studied the anti-inflammatory potential of five commercial 
mushroom species (Agaricus bisporus, Agaricus bisporus Portobello J.E.Lange, Flammulina 
velutipes (Curtis) Singer, Lentinus edodes, and Pleurotus ostreatus in LPS activated RAW 
264.7 macrophages cells for NO production and also detected TNF-α level using ELISA kit. 
Three mushroom species showed the highest activity with the result expressed in terms of 
IC50 for NO production and TNF-α release respectively: Pleurotus ostreatus	 (0.077 mg/mL 
and 0.035 mg/mL), Lentinus edodes	 0.027 mg/mL and 0.047 mg/mL) and Flammulina 
velutipes	0.024 mg/mL and 0.099 mg/mL). Gunawardena et al. (2014) also demonstrated the 
anti-inflammatory activity of extracts prepared from mushrooms after undergoing some food 
processing procedures. The results showed reduced activity compared to fresh samples, 
which implies that anti-inflammatory compounds present in these mushrooms were degraded, 
e.g due to suseptibility to heating. 
Ganoderma lucidum (Curtis) P. Karst., is a medicianal mushroom that has been used to 
reduce allergies, inflammation, has anti-tumor and anti-aging potential, as well as health 
promoting effects. Ethanolic extract of Ganoderma lucidum was studied for its anti-
inflammatory potential by stimulating murine BV2 cell line with LPS, and the amount of NO,  
PGE2 and Cytokine( IL-1β and TNF-α)  in culture supernatants quantified as reported by 
Yoon et al. (2013). Treatment of cell line with extract up to 1 µg/ml significantly repressed 
the production of NO due to the inhibition of iNOS mRNA protein expression. The amount 
of cytokine release was measured by ELISA and a significant reduction in the level of 
cytokines after treatment with extract was observed. The anti-inflammatory ativity was 
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further associated to the inhibition of the NF-κB signaling pathway by the ethanolic extract. 
Methanolic extract of Ganoderma lucidum was also evaluated by Chu et al. (2015). 
RAW264.7 monocytic cells were stimulated with LPS and treated with extract at different 
concentrations. From the result, 100 µg/ml of extract significantly inhibited NO production in 
the culture medium up to 85%. 
Moro et al. (2012) analysed six mushroom species from Spain (Boletus edulis Bull., 
Cantharellus cibarius Fr., Craterellus cornucopioides (L.) Pers., Lactarius deliciosus, (L. ex 
Fr.) S.F.Gray Agaricus bisporus and Pleurotus ostreatus) in what concerns the anti-
inflammatory activity of their methanolic extracts through NO production in LPS stimulated 
RAW 264.7 cells. At a concentration of 0.5 mg/mL, Agaricus bisporus, Cratarellus 
cornucopioides, Cantharellus cibarius and Lactarius deliciosus showed 35%, 65%, 80% and 
40% of NO production inhibition, respectively. The release of TNF-α production was 
estimated by ELISA kits, but methanolic extracts showed no reduction of TNF-α production 
in the macrophages. 
Taofiq et al. (2015) studied the anti-inflammatory activity of ethanolic extracts of ten wild 
and four cultivated mushroom species from the Northeast of Portugal.  RAW 264.7 
macrophage cells were stimulated with LPS and then the amount of NO production was 
quantified using the griess reagent assay. The IC50 value responsible for 50% inhibition of 
NO production estimated and among the studied species was as follows: Pleurotus ostreatus 
presented the best results (96 µg/mL), followed by Macrolepiota procera (Scop.) Singer (162 
µg/mL), Boletus impolitus Fr. (166 µg/mL) and Agaricus bisporus (190 µg/mL). In oposition, 
ethanolic extracts of Agaricus bisporus Portobello, Boletus edulis and Boletus flagrans 
Vittad., did not display activity. 
Kim et al. (2004) studied the Phellinus linteus (Berk. & M. A. Curtis) Teng, an orange colour 
mushroom used in China, Japan and other oriental countries for health maintenance. The 
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ethanolic extracts obtained from the fresh fruiting bodies of P. linteus were investigated in 
vivo for anti-inflammatory potential based on their ability to inhibit inflammation (edema) 
induced by croton oil in mice.  Topical aplication of extract at 1.0 mg per ear gave 41.5% 
edema inhibition, when compared with indomethacin, which gave rise to a quite higher 
inhibition (71.7%). Kim et al. (2006) also demonstrated the anti-inflammatory activity of the 
ethanolic extracts of P. linteus in LPS-stimulated RAW264.7 macrophages. The extracts at 
different concentrations dependently reduced iNOS promoter activity and NO production; at 
0.5 mg/mL, the extract had 60% of NO production inhibition. 
Cordyceps, a genus of mushroom known to grow on insects and have been reported to 
strengthen the immune system (Won & Park, 2005). Rao, Fang, Wu, & Tzeng (2007), studied 
anti-inflammatory activity using methanolic extracts from the fruiting body of Cordyceps 
sinensis (Berk.) Sacc., and by stimulating macrophages cells with LPS and NO production 
later quantified. The amount of TNF-α level and IL-12 were quantified by the ELISA test. 
From the results, 100 µg/mL of C. sinensis extract inhibited NO production by 70%. Han, 
Oh, & Park (2011) also studied the anti-inflammatory effect of hot water extract of 
Cordyceps militaris (L.) Fr. in vivo by inducing inflammation in mice. The extracts were 
known to inhibit inflammation as well as iNOS and TNF-mRNA expression in colon tissue 
of DSS-induced colitis and in LPS-stimulated RAW264.7 cells. Kim et al. (2003) also 
described the anti-inflammatory activity of another Cordyceps specie. Methanolic extracts of 
C. pruinosa (L.) Fr. were tested in vitro for inhibition of pro-inflammatory cytokines 
production by using ELISA kit as well as NO production in LPS stimulated RAW264.7 
macrophages. The extracts were known to suppress gene expression of IL-1β, TNF-α, 
inducible nitric oxide synthase, and cyclooxygenase-2 enzyme. This is due to the inhibition 
of nuclear transcription factor NF-κB activation. 
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5.2. Polysaccharides 
Mushrooms have been known as valuable sources of bioactive carbohydrates, namely 
polysaccharides which represent the main group with various health promoting properties 
(Villares, 2013). They include several different β-glucans (Supplementary material S3), 
fucomannogalactans, xylomannans and mannogalactans, known to play different biological 
roles such as the ones of antioxidation, anti-inflammatory, antitumour, antimicrobial, anti-
aging, neuroprotective and immunomodulatory (Li et al., 2013).  
Studies on the anti-inflammatory properties of carbohydrates have led to positive results as 
shown in Table 2. Several types of polysaccharides have been obtained from mushroom dry 
fruiting bodies or mycelia and tested for anti-inflammatory activity either in vivo (Lu et al., 
2008; Ruthes et al., 2013c; Silveira et al., 2015), following a typical model similar to human 
acute inflammation, or in vitro for inhibition of cytokine or NO production (Dore et al., 2007; 
Chang et al., 2013; Castro et al., 2014). 
Several pharmacological properties have been reported on the extracts and bioactive 
compounds isolated from Cordyceps militaris, namely the anti-inflammatory activity (Rao, et 
al., 2010). D-Glucose, D-mannitol and 3,4-O-isopropylidene-D-mannitol were isolated from 
its fruiting body and the anti-inflammatory potential evaluated in mouse peritoneal 
macrophages regarding the inhibition of NO production and cytokine release. Among the 
three cited compounds, D-Glucose showed the highest NO inhibition potential with an IC50 
value of 11.3 µg/mL, followed by D-mannitol (14.2 µg/mL) and 3, 4-O-isopropylidene-D-
mannitol (17.2 µg/mL). They also inhibit significantly cytokines (TNF-α and IL-12) 
production, indicating that they may be useful compounds for the design of anti-
inflammatory agents. 
Mushroom polysaccharides vary in structure and sometimes they exhibit different biological 
effects. Silveira et al. (2014) isolated a (1→3)-β-D-glucan from the fruiting body of 
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Pleurotus sajor-caju (Fr.) Singer and tested its anti-inflammatory effect in a monocytic cell 
line THP-1 after LPS induction, for inhibition of pro-inflammatory genes production.  
Monocyte cells showed a significant decrease in TNF-α expression (61.8% inhibition) while 
IL-1β and COX-2 mRNAs were also significantly inhibited (37.0% and 63.6%, respectively). 
Silveira et al. (2015) isolated a mannogalactan from P. sajor-caju by submerged 
fermentation. The purified polysaccharide was chemically characterized and its anti-
inflammatory potential evaluated in vivo for reduction of carrageenan-induced paw edema in 
mice. The group treated with purified mannogalactan was able to reduce edema after 5-6h of 
exposure to 1% carrageenan, with 69-71% edema reduction observed, and was quite as 
effective as dexamethasone used as control. Therefore, mushroom polysaccharides have 
shown to be lead compounds for development of anti-inflammatory agents. 
Agaricus bisporus is one of the most commonly consumed mushrooms in the world. Ruthes 
et al. (2013b) isolated and purified a fucogalactan from its dried fruiting bodies, and its anti-
inflammatory effect was evaluated in vivo by formalin-induced pain in mice and detection of 
iNOS and COX-2 protein expression. Fucogalactan significantly decreased both iNOS and 
COX-2 expression by 53% and 54%, respectively, in relation to dexametasone used as 
control, which also affected both iNOS and COX-2 expression by 74.5% and 71.4%, 
respectively. The results reported showed significant inhibition of inflammatory pain and 
strongly confirm the anti-inflammatory potential of fucogalactan. 
Xu, Yasuda, Nakamura-Tsuruta, Mizuno, & Ashida (2012) isolated a β-glucan (lentinan) 
from the fruiting bodies of Lentinus edodes and investigated this effects on NO and TNF-α 
production in LPS stimulated murine RAW 264.7 macrophages. Lentinan, at a concentration 
of 200 µg/mL, was found to significantly inhibit NO production (70%) and was dose-
dependent. Also the amount of TNF-α released from RAW 264.7 cells was quantified and 
found to be suppressed by 75% at 200 µg/mL. Furthermore, the protein expression of iNOS 
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and the gene expression of iNOS mRNA and TNF-α mRNA were suppressed by lentinan 
suggesting its usefulness as an anti-inflammatory agent. Mizuno, Nishitani, Hashimoto, & 
Kanazawa (2009) also reported the anti-inflammatory effect of this compound, which was 
analysed for inhibition of TNF-α production as well as IL-8 expression. At 500µg/mL, it was 
able to down regulate IL-8 mRNA expression in RAW 264.7 stimulated with LPS. 
 
5.3. Terpeneoids 
Terpenoids are organic compounds found in plants, animals and macrofungi. They are 
empirically regarded as built up from isoprene, a hydrocarbon consisting of five carbon atoms 
with molecular formula (C5H6)n as repeating unit (El Enshasy & Hatti-Kau, 2013). The 
terpene compounds are named based on the number of isoprene units, for example, 
monoterpenes (10 carbons), sesquiterpenes (15 carbons), diterpenes (20 carbons), 
sesterterpenes (25 carbons), triterpenes (30 carbons), and tetraterpenes (40 carbons). Among 
the large number of terpenes, triterpenoids are exclusively found in certain macrofungi, 
mainly Basidiomycetes, and are recognized for their biological activity and medicinal 
purposes. Several researchers have isolated some of these terpenoid coumpounds from 
mushrooms and, among them; the titerpenoids are the most reported (Table 3). Their ability 
to induce significant decrease in NO production as well as other cytokines was evaluated. 
Common examples include ganoderol, ianostane, lucidadiol and lucidone (Supplementary 
material S4) isolated, from the fruiting body of Ganoderma lucidum (Akihisa et al., 2007; 
Dudhgaonkar, Thyagarajan, & Sliva, 2009; Choi et al., 2014a).  
Ganoderma lucidum has been used in the past to promote health and longevity in Asia. Choi 
et al. (2014a) isolated 12 triterpenes from its fruiting body and the anti-inflammatory activity 
evaluated in LPS induced RAW 264.7 cells. Seven triterpenes; butyl lucidenate E2 (GT-1), 
butyl lucidenate D2 (GT-2), butyl lucidenate P (GT-3), butyl lucidenate Q (GT-4),  
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Ganoderiol F (GT-5), methyl ganodenate J (GT-7) and butyl lucidenate N (GT-12), out of the 
studied twelve triterpenes, showed significant decrease in NO production. 20 µM of GT-2 
showed up to 70% inhibition of NO production relative to the control. Dudhgaonkar, 
Thyagarajan, & Sliva (2009) also studied triterpene rich ethanolic extracts from G. lucidum in 
LPS stimulated RAW 264.7 macrophage cells. The extract at 10–50 µg/mL suppressed TNF-
α production in RAW 264.7 cells (IC50 15.1 µg/mL), reduced IL-6 production (IC50 14.4 
µg/mL) and decreased the secretion of PGE2 and NO in a dose-dependent manner with IC50 
values of 28.2 µg/ml and 11.4 µg/mL, respectively. 
Cyathus africanus H. J. Brodie, also known as “bird nest fungi”, usually grows on animal 
dungs, woody debris and soil rich in humus. Han et al. (2013) isolated diterpenes from its 
fruiting body and the anti-inflammatory activity was evaluated regarding NO production in 
LPS induced macrophages. Five diterpenes showed potent NO inhibition with IC50 values of 
2.57, 1.45, 12.06, 10.73, and 9.45 µM, compared to hydrocortisone used as the control with 
IC50 value of 53.78 µM. 
Piptoporus betulinus (Bull. ex Fr.) P. Karst., also known as “bracket fungi” is an edible 
mushroom that is geographically restricted to the cold climates. Kamo, Asanoma, Shibata, & 
Hirota, (2003) isolated six lanostane-type triterpene acids from its fruiting bodies collected in 
Japan. The anti-inflammatory activity was tested in vivo by inducing inflammation (edema) 
in mouse ear using TPA (12-O-tetradecanoylphorbol-13-acetate). The isolated compounds 
suppressed the TPA-induced edema up to 49-86% at 400 nmol/ear application. Some of the 
isolated compounds (polyporenic acids A, three derivatives of polyporenic acid A and a novel 
compound (+)-12α, 28-dihydroxy-3α-(3′-hydroxy-3′-methylglutaryloxy)-24-methyllanosta-8, 
24(31)-dien-26-oic acid) have displayed higher activity than indomethacin used as positive 
control. 
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5.4. Polyphenols 
Phenolic compounds are characterized by at least one aromatic ring (C6) and one or more 
hydroxyl groups (Michalak, 2006). These molecules, including phenolic acids, are a group of 
secondary metabolites from fungi and plants, secreted for protection against UV light, 
insects, viruses and bacteria (Heleno, Martins, Queiroz, & Ferreira, 2015). Mushrooms are 
known to produce an amazing diversity of secondary metabolites. Phenolic compounds are 
one of the most important groups of these metabolites, being attractive because of their 
multifunctional properties. These compounds provide protection against several chronic 
diseases such as cancer, brain malfunction and several cardiovascular illnesses. Different 
research studies have reported the bioactive potential of phenolic acids, but only few studied 
the bioactive properties of their synthesised metabolites (Heleno, Martins, Queiroz, & 
Ferreira, 2015).		
Several classes of phenolic compounds (Supplementary material S5) and some of their 
derivatives, present in mushroom extracts, have been evaluated and known to have anti-
inflammatory activity (Table 4). 
Antrodia camphorata, very common in Taiwan, has enormous amount of bioactive 
compounds with reported pharmacological potential (Geethangili & Tzeng, 2011). Several 
benzenoids and benzene derivatives have been isolated from A. camphorata and tested for 
anti-inflammatory activity. Chen et al. (2013) isolated three new benzenoids from A. 
camphorata and evaluated their anti-inflammatory activity in LPS induced RAW 264.7 cells 
regarding the inhibition of NO production. The IC50 values of the three compounds (3-
isopropenyl-2-methoxy-6-methyl-4,5-methylenedioxyphenol (1), 4,4'-dihydroxy-3,3'-
dimethoxy-2,2'- dimethyl-5,6,5',6'-bimethylenedioxybiphenyl (2), 2,3-methylenedioxy-4-
methoxy-5-methylphenol (3) ) were 1.8, 18.8 and 0.8 µg/mL. Other phenolic derivatives from 
A. camphorata are antrocamphin and benzocamphorin that have attracted considerable 
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attention recently because of their significant anti-inflammatory activity. Liao, Kuo, Liang, 
Shen, & Wu (2012) isolated benzocamphorin F from the fruiting body of Taiwanofungus 
camphoratus and evaluated its anti-inflammatory activity in murine microglial cells (BV2). 
Inhibition of NO production was expressed in terms of IC50 and the compound reached a 
value of 8.6 µM compared to L-NAME, a non-specific NOS inhibitor, with an IC50 of 12.0 
µM. 
Albatrellus caeruleoporus (Peck) Pouzar is an edible mushroom that grows on woody debris 
as well as on the ground, common in North America. Quang et al., (2006b) chemically 
characterized its methanolic extracts in terms of phenolic acids and evaluated their anti-
inflammatory potential in LPS induced RAW 264.7 cells regarding NO production. All four 
identified grifolin derivatives showed a significant reduction in NO production with IC50 
values of 23.4, 22.9, 29.0, and 23.3 µM compared to 88.4 µM of NG-methyl-L-arginine (L-
NMMA), a potent inhibitor of NO production used as control. 
Elaphomyces granulatus Fr. is an inedible mushroom known as “false truffle” in the United 
Kingdom and widely distributed in Europe and North America. Stanikunaite, Khan, Trappe, 
& Ross (2009) studied the ethanolic extracts of E. granulatus and isolated syringaldehyde 
and syringic acid from its fruiting body. Extracts and phenolic acids were evaluated for their 
anti-inflammatory activity in RAW 264.7 macrophages cells by the COX-1- and COX-2-
catalyzed prostaglandin biosynthesis assay. The extracts caused a 68% inhibition of COX-2 
activity at 50 µg/mL. Syringaldehyde and syringic acid moderately inhibited COX-2 activity 
with IC50 values of 3.5 µg/mL and 0.4 µg/mL, respectively. NS-398, a specific inhibitor of 
COX-2, was used as a positive control and had IC50 0.2 µg/mL. 
Phellinus linteus is a medicinal mushroom used for centuries in oriental countries to prevent 
several diseases (Kim, Song, Kim, Kim, Lim, & Park, 2004). Several phenolic compounds 
have been isolated from the fruiting body and mycelia of P. linteus; among them are caffeic 
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acid, hispolon, hispidin, hydroxybenzaldehyde and inotilone (Huang, Huang, & Deng, 
2012a). Lin et al. (2014b) isolated hispolon from fermentation broth of P. linteus and its anti-
inflammatory activity was evaluated in LPS induced RAW 264.7 cells regarding inhibition of 
NO production. Hispolon at 10 mg/mL inhibited NO production by 72.1% and suppressed the 
expression levels of iNOS. Hence this compound has useful therapeutic potential, additional 
research studies need to be conducted in order to understand its mechanism of action. Huang, 
Huang, & Deng (2012a) isolated inotilone, another important phenolic compound with 
reported anti-inflammatory potential, from the fruiting body of P. linteus and tested the anti-
inflammatory effects in vivo in carrageenan induced hind mouse paw edema model as well as 
in vitro for inhibition of NO production and iNOS expression. Carr-induced mouse paw 
edema volume was significantly decreased to 56.2%, NO production was inhibited up to 
26.2–59.7%, TNF-α release was inhibited up to 10.6–40.3% while iNOS expression was 
significantly inhibited in a dose-dependent manner.  Inhibition of NF-kB and MAPK 
activation were also observed and are the major mechanisms responsible for cytokine and 
other inflammatory mediator release. 
 
5.5. Steroids		
Steroids are organic compounds with three hexagonal and one pentagonal carbon rings 
arranged in specific configuration with several functional groups found in plants, animals and 
fungi (Streck, 2009).	Ergosterol is a precussor of vitamin D found in mushrooms membrane 
and known to vary among species depending on the physiological state of the mushroom 
(Chiocchio & Matković, 2011). Steroids in general have been reported to play several 
biological functions such as anti-tumor, anti-oxidant, immune function as well as prevention 
of common diseases (Phillips et al., 2011). 	
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Steroids (Table 5) such as trametenolic acid, ergosterol peroxide, and ergosterol 
(Supplementary material S6) have been isolated from mushrooms and were reported to 
present anti-inflammatory activity. 
Inonotus obliquus (Ach. ex Pers.) Pilát, also known as "chaga mushroom" is a medicinal 
mushroom used in Russia and other North-European countries. Among others, anti-tumour 
and immunomodulatory properties were reported (Fan, Ding, Ai, & Deng, 2012). Ma, Chen, 
Dong, & Lu (2013) isolated six main constituents from its fruiting body and their anti-
inflammatory activity was evaluated for NO production in RAW 264.7 cell lines. Among the 
isolated compounds, ergosterol peroxide and trametenolic acid had the highest anti-
inflammatory potential and significantly inhibited NO production by 36.88% and 50.04%, 
respectively. Other steroidal compounds isolated from mushrooms (e.g. lanosterol, 3β-
hydroxy-8, 24-dien-21-al, ergosterol and inotodiol) had relatively low percentages of NO 
production inhibition. 
Antrodia camphorata is a medicinal mushroom with reported anti-inflammatory activity 
(Hseu et al., 2005; Liu et al., 2007; Hsieh et al., 2010; Hseu, Huang, & Hsiang, 2010; Lee et 
al., 2011b;	 Liao, Kuo, Liang, Shen, & Wu, 2012; Deng et al., 2013; Chen et al., 2013). 
Ergostatrien-3β-ol was isolated from the fruiting body of A. camphorata by submerged 
fermentation (Huang et al., 2010). The anti-inflammatory activity was evaluated in vivo for 
reduction of NO production as well as for serum levels of TNF-α using a commercial ELISA 
kit. This compound significantly inhibited NO and TNF-α levels after Carrageenan injection 
and inhibited iNOS and COX-2 protein expression in the animal model. These results suggest 
that the compound may be useful to develop new anti-inflammatory agents, and the 
mechanism of action may be related to inhibition of iNOS expression.  
Pleurotus species are among the most cultivated edible muhrooms in the world with high 
nutritional value and reported medicinal properties. Several Pleurotus species have been 
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studied for the anti-inflammatory effect of their extracts as well as their bioactive 
metabolites; examples are Pleurotus citrinopileatus Singer; Pleurotus eryngii (DC.) Quél; 
Pleurotus florida Singer; Pleurotus ostreatoroseus Singer; Pleurotus ostreatus (Jacq. ex Fr.) 
P. Kumm.; Pleurotus pulmonarius (Fr.) Quél; Pleurotus sajor-caju (Fr.) Singer and Pleurotus 
tuber-regium (Rumph. ex Fr.) Singer. Liu et al. (2014) reported the anti-inflammatory 
activity of ethanolic mycelia extract of Pleurotus tuber-regium produced by submerged 
fermetation broth in LPS induced murine macrophage cell line RAW 264.7. Two compounds, 
cerevisterol (CE) and ergosta-4, 6, 8(14), 22-tetraen-3-one, were isolated, characterised and 
their anti-inflammatory activity evaluated. From the result, both compounds at 10µM 
inhibited NO production in a dose dependent manner, very similar to control. They also 
significantly inhibited TNF-α, IL-6, and PGE2 release from the cell culture supernatant. The 
anti-inflammatory activity was reported to be due to down regulation of iNOS and COX-2 
mRNA protein expression. 
 
5.6. Other metabolites 
Beside the major compounds with reported anti-inflammatory activity, other bioactive 
metabolites (Supplementary material S7) such as fatty acids, succinic and maleic 
derivatives, adenosine, cordycepin and glycopeptides have been studied (Table 6) and known 
to inhibit the production of inflammatory mediators as well as to suppress the induced 
inflammation in vivo. 
Fomes fomentarius is an inedible mushroom specie common in Europe, Asia and North 
America, known for its large fruiting body and decomposing property. Its fruiting body was 
extracted with methanol and methyl 9-oxo-(10E, 12E)-octadecadienoate isolated (Choe, Yi, 
Lee, Seo, Yun, & Lee, 2015). The anti-inflammatory activity was evaluated in peritoneal 
macrophages for NO, PGE2 production, TNF-α and IL-6 release. At 20 µg/mL, the 
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compound significantly inhibited NO and PGE2 by 65% and 50%, respectively, while TNF-α 
and IL-6 levels were inhibited up to 35% and 13%, respectively. Finally, the mechanism of 
action of the compound was found to be due to inhibition of iNOS and COX-2 protein 
expression and also due to a slight inhibition of phosphorylation of ERK1/2 kinase. 
Polysaccharide protein complexes obtained from mushroom have been known to play several 
biological functions such as immunomodulatory, antitumour and antioxidant (Wu, Chen, & 
Siu, 2014). The anti-inflammatory activity of several glycoproteins have been reported by 
some authors (Chen, De Mejia, & Wu, 2011; Lau, Abdullah, Aminudin, Lee, & Tan, 2015). 
The anti-inflammatory activity of a glycopeptide from Ganoderma capense (Lloyd) Teng 
was evaluated in RAW264.7 cells for NO production and for iNOS enzyme activity (Zhou, 
Chen, Ding, Yao, & Gao, 2014). It was found that LPS-induced NO production and iNOS 
expression were significantly inhibited in a dose-dependent manner. 
Many studies have reported the fatty acids composition of commercial and wild mushroom 
species (Barros, Baptista, Correia, Casal, Oliveira, & Ferreira, 2007). Agaricoglycerides is a 
fungal secondary metabolite made up of esters of chlorinated 4-hydroxy benzoic acid and 
glycerol. Han & Cui (2012) isolated this compound from fermented broth of Grifola frondosa 
(Dicks.) Gray and evaluated its anti-inflammatory activity by measuring in vivo levels of 
COX-2, ICAM-1, and iNOS. TNF-α and IL-1β levels were also quantified using an ELISA 
kit. Exposure to the compound at 500 mg/kg significantly decreased the level of IL-1β and 
TNF-α, and suppressed iNOS expression in LPS induced cells. 
 
5.7 Commercial and synthesised compounds 
Researchers have attempted to synthesize compounds with improved properties as drug 
candidates with the potential to inhibit production of NO and other inflammatory mediators 
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such as interleukins (IL 1β, IL-6, IL-8), TNF-α and PGE2. Some synthesised and commercial 
compounds with positive anti-inflammatory potential have been reported (Table 7).  
Taofiq et al. (2015) studied the anti-inflammatory activity of commercial phenolic acids (p-
hydroxybenzoic and p-coumaric acids) and cinnamic acid, and of their synthesised 
metabolites (glucuronated p-coumaric acid, methylated p-coumaric acid, glucuronated  
cinnamic acid, methylated cinnamic acid, methylated p-hydroxybenzoic acid, glucuronated p-
hydroxybenzoic acid) from parental phenolic acids (Heleno, Ferreira, Calhelha, Esteves, & 
Queiroz, 2014). All compounds were then tested for their potential to inhibit NO production 
in LPS stimulated RAW 264.7 cells. Cinnamic acid had the highest activity (IC50 value 182 
µM), followed by p-hydroxybenzoic (239 µM) and p-coumaric (442 µM) acids, in 
comparison with dexamethasone (40 µM) used as control. Among the synthesized 
metabolites, CoA-GP (glucuronated derivative of p-coumaric acid) and CoA-M1 (methylated 
derivative with the methoxy group at the para position) presented strong anti-inflammatory 
activity with IC50 values of 58 µM and 35 µM, respectively. 
Several publications have reported the medicinal properties of Cordyceps mushroom, 
including the anti-inflammatory activity (Kim et al., 2003; Won & Park, 2005; Rao, Fang, & 
Tzeng, 2007; Rao, Fang, Wu, & Tzeng, 2010; Han, Oh, & Park, 2011). This mushroom 
contains a lot of bioactive compounds and "Cordycepin" an adenosine analogue is the most 
important one. Jeong et al. (2010) studied the anti-inflammatory activity of commercial 
cordycepin in LPS stimulated murine BV2 microglia cells for inhibition of NO production as 
well as PGE2, and pro-inflammatory cytokine release. Cordycepin at 7.5 µg/mL, decreased 
levels of NO production up to 65% while the PGE2 concentration measured using ELISA kit 
was also repressed up to 60%. This anti-inflammatory mechanism was found to be due the 
inhibition of iNOS and COX-2 protein expression. Choi et al. (2014b) also studied the anti-
inflammatory potential of cordycepin in LPS stimulated RAW 264.7 macrophage cell line for 
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NO production, cytokine (TNF-α and IL-1β) levels and PGE2 production. At 30 µg/mL 
exposure of induced cells to cordycepin, there was significant decrease in NO, TNF-α, IL-1β 
and PGE2 levels. The mechanism of inhibition was further confirmed by decreased levels of 
LPS-induced NF-κB/p65 levels in the nucleus and inhibition of phosphorylation of IkB-α 
complex. 
 
6. Concluding remarks 
The present review focuses on the anti-inflammatory activity of some important worldwide 
edible, wild and medicinal mushrooms as well as on the bioactive metabolites they contain, 
which are responsible for the imparted anti-inflammatory activity. Research studies available 
in literature, on both edible and inedible mushroom species, highlight their anti-inflammatory 
activity, conclusion drawn mainly based on the extracts evidences and not on the bioactive 
compounds themselves. Among the existing mushroom species, Agaricus bisporus, Phellinus 
linteus, Cordyceps species, Antrodia camphorate, Pleurotus species and Ganoderma lucidum 
have been the most extensively studied. 
Nevertheless the intensive research done in field, it is difficult to compare results reported by 
different researchers, partly due to the diverse methodologies used to evaluate the anti-
inflammatory activity of both mushroom extracts and isolated compounds. Among them, 
nitric oxide assay is the most widely used assay for in vitro measurement of NO production in 
LPS stimulated RAW 264.7 cells. Other methods include in vitro evaluation of TNF-α 
inhibition in LPS activated THP-1 monocytic cell, measurement of inhibition of expression 
of iNOS, COX-2 and other pro-inflammatory mediators using cytokine enzyme linked 
immunosorbent assay (ELISA) kit and COX-1- and COX-2-catalyzed prostaglandin 
biosynthesis assay.	 In what concerns	 in vivo anti-inflammatory studies, many have been 
carried out by inducing inflammation in mice either by croton oil-induced ear edema test, the 
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carrageenin-induced paw edema model, TPA (12-O-tetradecanoylphorbol-13-acetate) 
induced ear edema or xylene induced edema and the activity of the extracts or compounds 
evaluated by observed reduction of edema. 
 Also the IC50 values, concentration responsible for 50% inhibition of inflammatory 
mediators production, even for the same mushroom species using the same anti-inflammatory 
assay, might be different as the bioactive compounds are released depending upon the type of 
cultivation environment, solvent and extraction procedure, extraction time and mushroom 
maturation..  
Among the several bioactive compounds isolated from mushrooms and studied for anti-
inflammatory activity, polysaccharides, terpenes and phenolic derivatives are the most 
implicated and known to show positive bioactivity. Only few research studies reported the 
bioactivity of ergosterol, fatty acids, glycopeptides, and nucleic acid analogues as well as of 
other metabolites. 
Hence, mushrooms have valuable therapeutic compounds whose mechanism of action need to 
be fully elucidated and corroborated by conducting clinical trials in order to confirm the 
effectiveness of some of these mushroom-based inhibitors of NF-κB pathway as well as 
inhibition of the cyclooxygenase enzyme responsible for expression of many inflammatory 
mediators. This will consolidate the basis for the development of mushroom-based 
nutraceuticals or drugs effective against inflammation. 
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Figure 1. Schematic diagram of nuclear factor-κB (NF-κB) pathway. Macrophage cells 
express membrane receptors such as toll-like receptors (TLRs) and tumor necrosis factor 
receptors (TNFR). These receptors recognize pro-inflammatory stimuli such as 
lipopolysaccharides and viral proteins. Attachment of these pathogen-associated molecular 
patterns (PAMPs) to membrane receptors activates the myeloid differentiation protein 88 
(MyD88). MyD88 activates specific protein kinases that are responsible for activation of IKK 
kinase (IKKα, IKKβ, IKKγ). This kinase further phosphorylates IkB-α complex leading to 
dissociation of the complex, and its proteasomal degradation, allowing NF-kB to translocate 
to the nucleus, where it binds to specific DNA sequences encoding the pro inflammatory 
cytokines (e.g., IL-1, IL-2, IL-6, TNF-α as well as Cyclooxygenase-2 (Cox-2) and inducible 
nitric oxide synthase (iNOS). 
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Figure 2. Schematic diagram of the biosynthetic pathway of common prostaglandins. 
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Table 1. Previous studies on anti-inflammatory activity of different mushroom species. 
Mushroom Origin Extract Assay Mechanism of action Reference 
Agaricus bisporus	J.E.Lange Spain Methanol 1, 2 Inhibited NO production, level of TNF-α released Moro et al., 2012 
 Australia Ethanol 1,2 Reduced level of NO,  TNF-α Gunawardena et al., 2014 
 Portugal Ethanol 1 Inhibited NO production Taofiq et al., 2015 
A. bisporus Portobello J.E.Lange Australia Ethanol 1,2 Reduced level of NO,  TNF-α Gunawardena et al., 2014 
Agaricus blazei Murill Japan n.m. 2 Decreased level of  IL-6, IL-8 and IL-10 Bernardshaw et al., 2006 
 Brazil Water 4 Reduced edema Mourão, et al., 2011 
 Korea Methanol 2 Inhibited IL-6, PGD2 release Song et al., 2012 
Amauroderma rugosum (Blume 
& T. Nees) Torrend 
Malaysia Ethanol 1 Inhibited NO production Chan et al., 2013 
 Malaysia Ethanol 1, 2 Inhibited NO production, suppressed TNF-α release Chan et al., 2015 
Antrodia camphorata (M.Zang & 
C.H.Su) Sheng H.Wu, Ryvarden 
& T.T.Chang 
Taiwan n.m. 2 Inhibited TNF-α, IL-1β and NF-κβ Hseu et al., 2010 
 Taiwan Water and 
methanol 
5 Inhibited edema Liu et al., 2007 
 Taiwan n.m. 1, 2 Reduced NO, TNF-α & IL-1β production Hseu et al., 2005 
Antrodia cinnamomea Chang & 
Chou 
Taiwan Methanol 1 Inhibited NO, TNF-α, IL-6 production and COX-2 
expression 
Wen et al., 2011 
Antrodia salmonea T.T. Chang & 
W.N. Chou 
Taiwan Ethanol 1, 2, 4 Reduced NO and Cytokine release, paw edema inhibition Huang et al 2012b. 
Boletus impolitus Fr. Portugal Ethanol 1 Inhibited NO production Taofiq et al., 2015 
Cantharellus cibarius	Fr. Spain Methanol 1, 2 Inhibited NO & level of TNF-α released Moro et al., 2012 
Cordyceps militaris (L.) Fr. Korea 70% 
Ethanol 
3, 4 Inhibited Inflammation Won et al., 2005 
 Korea Water 1, 2 Inhibited NO production, IL-6 and TNF-α inhibition Joung, et al., 2014 
 Korea Boiling 
water 
1 Reduced level of NO, inhibition  iNOS mRNA expression Han et al., 2011 
Cordyceps pruinosa (L.) Fr. Korea Methanol 1 Inhibited NO production. Kim et al., 2003 
Cordyceps sinensis (Berk.) Sacc. Taiwan Methanol 1, 2 Reduced NO, TNF-α and  (IL)-1β production Rao et al., 2007 
Coriolus versicolor (L.) Quél China Ethanol, 2 Suppressed production of IL-2 Ho et al., 2004 
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water 
 Korea 70% 
ethanol 
2 Reduced expression of TNF-α, IL-1β and IL-6. Lim, 2011 
Daedalea gibbosa (Pers.) Israel Ethyl 
acetate 
1, 2 Reduced level of NO via decreased iNOS promoter 
activity, reduced TNF-α 
Ruimi et al., 2010b 
Flammulina velutipes (Curtis) 
Singer  
Australia Ethanol 1,2 Reduced level of NO, TNF-α Gunawardena et al., 2014 
Ganoderma lucidum (Curtis) P. 
Karst. 
Taiwan Water, 
80% 
methanol 
1 Reduced level of NO Chu et al., 2015 
 Korea 25% 
ethanol 
1, 2 Inhibited NO, PGE2, IL-1β and TNF-α  Yoon et al., 2013 
Inonotus obliquus (Ach. ex Pers.) 
Pilát 
Korea Hot 
methanol 
1 Inhibited NO production  
 
Park et al., 2005 
 Canada Ethanol 1, 2 Inhibited NO production, level of TNF-α released Van et al., 2009 
Lactarius deliciosus (L. ex Fr.) 
S.F.Gray  
Spain Methanol 1, 2 Inhibited NO production, level of TNF-α released  Moro et al., 2012 
Lentinus edodes (Berk.) Pegler Australia Ethanol 1,2 Reduced level of NO, TNF-α Gunawardena et al., 2014 
Lentinus polychrous (L.) Fr. Thailand 80% 
Ethanol 
1, 2 Inhibited NO & TNF-α levels, suppressed iNOS activity  Fangkrathok et al., 2013 
Lignosus rhinocerotis (Cooke) 
Ryvarden 
Malaysia Water and 
methanol 
2, 4 Reduced paw swelling, reduced level of TNF-α Lee et al., 2014 
Macrolepiota procera, (Scop.) 
Singer  
Portugal Ethanol 1 Inhibited NO production  Taofiq et al., 2015 
Marasmius oreades (Bolton) Fr Israel Ethyl 
acetate 
1 Reduced level of NO Ruimi et al., 2010a 
 
Naematoloma sublateritium (Fr.) 
P. Karst 
Korea Ethanol 2 Reduced TNF-α release, inhibited NF-κB activation Lee et al., 2012 
Phellinus baumii Pilát Korea Methanol  1, 2 Reduced level of NO, inhibited PGE2,  
IL-1β, IL-6 expression 
Yayeh et al., 2012 
Phellinus linteus (Berk. & M. A. 
Curtis) Teng 
Korea 70% 
Ethanol 
1 Decreased iNOS promoter activity and NO production  Kim et al., 2006 
 Korea 70% 
Ethanol	
3 Inhibited inflammation Kim et al., 2004 
 Korea 70% 
Ethanol 
1 Inhibited NO production Kim et al., 2007 
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 Taiwan n.m. 1, 2 Inhibited NO and TNF-α production Lin et al., 2014b  
 Korea Ethanol, 
Ethyl 
acetate 
1, 2 Inhibited NO and PGE2 production Song et al., 2014 
Pleurotus eryngii (DC.) Quél. Taiwan Ethanol 1, 2 Reduced level of NO, inhibition of PGE2 release Lin et al., 2014a 
Pleurotus florida Singer India Methanol 4 Reduced edema Jose et al., 2004 
 Iran Water 1 Reduced level of NO Ghazanfari et al., 2009 
 Korea 60% 
acetone, 
80% 
methanol 
1, 4 Reduced level of NO, inhibited edema Im et al., 2014 
Pleurotus 
ostreatoroseus Singer 
Brazil ethanol 1 Inhibited NO production Corrêa et al., 2015 
Pleurotus ostreatus (Jacq. ex Fr.) 
P.Kumm.  
Portugal Ethanol 1 Inhibited NO production  Taofiq et al., 2015 
 Australia Ethanol 1,2 Reduced level of NO, TNF-α Gunawardena et al., 2014 
 USA Water  2 Inhibited production of TNF-α, IL-6, and IL-12  Jedinak et al., 2011 
Pleurotus sajor-caju (Fr.) Singer Malaysia 95% 
ethanol 
1 Reduced level of NO Saad et al., 2014 
Pleurotus tuber-regium (Rumph. 
ex Fr.) Singer 
Belgium 95% 
ethanol 
1, 2 Reduced level of NO, Inhibit TNF-α, and IL-6 release Liu et al., 2014 
Polyporus dermoporus Pers. Brazil Ethanol 1, 3, 4 Inhibited edema, reduced level of NO Dore et al., 2014 
Poria cocos  F.A.Wolf Korea Ethanol 1, 2 Inhibited NO, PGE2, TNF-α, and IL-1β production, 
suppressed NF-kB activity 
Jeong et al., 2014  
Russula virescens (Schaeff.) Fr. Korea 70% 
ethanol 
1, 2 Reduced level of NO and inhibition of TNF-α	 mRNA 
expression 
Hur et al., 2012  
Termitomyces albuminosus 
(Berk.) R.Heim  
China 80% 
Ethanol 
4, 6 Reduced edema  Lu et al., 2008 
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Tremella fuciformis Berk. Korea 80% 
methanol 
1 Reduced iNOS expression and NO production Li et al., 2014a 
Tricholoma matsutake Sing Korea Dichlorom
ethane 
1 Inhibited NO production Lim et al., 2007 
Tuber aestivum Vittad. Serbia Methanol 7 Inhibited COX-1 activity Beara et al., 2014 
Tuber magnatum Pico Serbia Methanol 7 Inhibited COX-1 activity Beara et al., 2014 
n.m.- not mentioned; 1- Nitric oxide assay; 2- Cytokine enzyme linked immunosorbent assay (ELISA); 3- Croton induced ear edema test; 4- Carrageenin-induced paw edema  test; 5- 
TPA (12-O-tetradecanoylphorbol-13-acetate) induced ear edema; 6- Xylene induced edema. 7- COX-1- and COX-2-Catalyzed prostaglandin biosynthesis assay in vitro. 
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Table 2. Polysaccharides isolated from mushrooms with reported anti-inflammatory activity. 
Mushroom Origin Bioactive compound Extraction solvent Assay Mechanism of action Reference 
Agaricus bisporus 
J.E.Lange  
Brazil Fucogalactan Water, ethanol 5 Decreased  iNOS and COX-2 expression  Ruthes et al., 2013b 
 Brazil Fucogalactan Chloroform, 
methanol 
7 Inhibited acetic acid induced 
inflammation 
Komura et al., 2010 
Agaricus blazei Murill China Soluble polysaccharide Water 2 Inhibited TNF-α, IL-1β, COX-2, iNOS, 
and ICAM-1 Levels 
Wang et al., 2013b 
Agaricus brasiliensis Peck Brazil Fucogalactan Chloroform, 
methanol 
7 Inhibited acetic acid induced 
inflammation 
Komura et al., 2010 
Agrocybe chaxingu Huaag Korea β-Glucan n.m. 1, 6  Inhibited NO production and edema 
formation 
Lee et al., 2009 
Amanita muscaria (L.) 
Lam. 
Brazil Fucomannogalactan Hot, cold water and 
aq. KOH 
5 Reduced formalin-induced inflammatory 
pain 
Ruthes et al., 2013c 
Armillariella mellea 
(Vahl) P.Kumm. 
Taiwan Polysaccharides and 
sulphated 
polysaccharides 
Hot water, 95% 
ethanol 
2 Inhibited TNF-α and IL-6 secretion Chang et al., 2013 
Caripia montagnei (Berk.) 
Kuntze 
Brazil β-Glucan chloroform-
methanol (1:1,v/v), 
80% acetone 
1, 3 Inhibited NO production, edema 
inhibition  
Castro et al., 2014 
 Brazil β-Glucan 80% acetone 1, 2, 3 Inhibited NO production, decreased 
cytokine release, edema reduction 
Queiroz et al., 2010 
Collybia dryophila  
(Bull.) P. Kumm. 
Canada (1→3),(1→4)  
β-Glucans  
85% ethanol 1 Inhibited NO production Pacheco-Sanchez et al., 
2006 
Cordyceps militaris (L.) 
Fr. 
Taiwan Glucose, D-mannitol, 
3,4-O-isopropylidene-
D-mannitol 
Methanol 1, 2 Inhibited NO production, decreased 
cytokine release 
Rao et al., 2010 
 Korea (1–3)-β-D-Glucan Chloroform-
methanol 
2 Inhibited IL-1β, TNF-α, COX-2 release. Smiderle et al., 2014 
Geastrum saccatum Fr. Brazil β-Glucan Acetone, water, 
ethanol 
1, 3, 6 Reduced nitrate/ nitrite and interleukin 
level  
Dore et al., 2007 
Lactarius rufus	(Scop.) Fr. Brazil (1→3),(1→6)-β-D-
Glucans 
Water, ethanol 5 Inhibited pain Ruthes et al., 2013a 
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Lentinus edodes (Berk.) 
Pegler 
Japan β-Glucan n.m. 1, 2 Inhibited NO production, level of TNF-α 
released 
Xu et al., 2012 
 Japan Lentinan n.m. 2 Down regulated IL-8 mRNA expression Mizuno et al., 2009 
 Brazil Heterogalactan Water 7 Inhibited acetic acid-induced 
inflammation 
Carbonero et al., 2008 
Pleurotus pulmonarius 
(Fr.) Quél. 
Israel Glucan Water, Ethanol 2 Inhibited TNF-α released from cells Lavi et al., 2010 
 Nigeria β-D-Glucan 95% Acetone 3 Inhibited edema formation Adebayo et al., 2012 
 Brazil (1→3),(1→6) β-glucan chloroform-
methanol 
7 Inhibited induced inflammation Smiderle et al., 2008 
Pleurotus sajor-caju (Fr.) 
Singer 
Brazil β-D-Glucan chloroform-
methanol (2:1, v/v), 
water and ethanol 
2 Inhibited production of pro-
inflammatory genes  
Silveira et al., 2014 
 Brazil Exopolysaccharide Ethanol 3 Reduced edema  Silveira et al., 2015 
Scleroderma nitidum 
Berk. 
Brazil β-Glucan 80% acetone 1, 2, 3  Reduced level of NO, IFN-γ, IL-2, IL-
10, suppresed paw edema 
Nascimento et al., 2012 
Termitomyces 
albuminosus (Berk.) 
R.Heim 
China Crude polysaccharide  80% Ethanol, water  3, 4, 5 Inhibition of edema formation  Lu et al., 2008 
n.m.- mot mentioned. 1- Nitric oxide assay; 2- Cytokine enzyme linked immunosorbent assay (ELISA); 3- Carrageenin-induced paw edema test; 4- Xylene induced edema; 5- 
Formalin test; 6- Croton induced ear edema test; 6- TPA (12-O-tetradecanoylphorbol-13-acetate) induced ear edema; 7- Acetic acid induced inflammation test 
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Table 3. Terpenes isolated from mushrooms with reported anti-inflammatory activity. 
Mushroom Origin Bioactive compound Extraction solvent Assay Mechanism of action Reference 
Antrodia camphorata 
(M.Zang & C.H.Su) Sheng 
H.Wu, Ryvarden & 
T.T.Chang 
Taiwan Eburicoic acid  
Dehydroeburicoic acid 
Methanol 1, 2, 5 Inhibited NO production and 
cytokine release; Suppressed 
Carrageenin -induced edema 
Deng et al., 2013 
Cyathus africanus H. J. 
Brodie 
China Diterpenoid Ethyl acetate 1 Inhibited NO production  Han et al., 2013 
Cyathus hookeri Berk. China Cyathane diterpenoid Ethanol 1 Inhibited NO production  Xu et al., 2013 
Fomitella fraxinea	(Bull.) 
Imazeki 
Japan Fomitellanols,cryptopo
ric acids,  
Isopropanol 3 Inhibited  COX-1 activit  
 
Yoshikawa et al., 2013 
Fomitopsis nigra (Berk.) 
Imaz. 
Korea Pachymic acid Methanol 2 Inhibition of ICAM-1, Cox-2, and 
iNOS expression 
Lee et al., 2013 
Fomitopsis pinicola (Sw.:Fr.) 
P. Karst. 
Japan Lanostane 
triterpenoids, triterpene 
glycosides 
70% Ethanol 3 Inhibited COX-2 activity  
 
Yoshikawa et al., 2005 
Ganoderma lucidum (Curtis) 
P. Karst. 
Korea Lanostane triterpenes Water and ethyl 
acetate 
1, 2 Inhibited NO production; suppressed  
iNOS and COX-2 expression  
Choi et al., 2014a Lee  
 USA Triterpene 95% ethanol 1, 2 Inhibited TNF-α, PGE2 and NO 
production; suppressed IL-6 
production 
Dudhgaonkar et al., 2009 
 Japan Triterpene acids Methanol 4 Suppressed TPA-induced edema Akihisa et al., 2007 
 Japan Triterpene butyl esters Methanol  Inhibited NO  production; suppressed  
iNOS and COX-2 activity 
Tung et al., 2013 
 China Ganoderic acid C1 Methylene chloride 2 Inhibited TNF-α production Liu et al., 2015 
Inonotus obliquus (Ach. ex 
Pers.) Pilát 
China Triterpenes Ethanol 1 Inhibited NO production  Ma et al., 2013 
Laetiporus sulphureus (Bull.) 
Murrill 
Korea Acetyl Eburicoic Acid Methanol 1 Inhibited NO production Saba et al., 2015 
Piptoporus betulinus (Bull. ex 
Fr.) P. Karst. 
Germany Lanostanoids Ethyl acetate, 
chloroform, 
methanol 
3 Inhibited COX-1 activity Kemami et al., 2004 
 Japan Lanostane-Type 
Triterpene 
Methanol 4 Suppressed TPA-induced edema  Kamo et al., 2003 
Poria cocos F.A.Wolf China 29-hydroxypolyporenic 
acid C, polyporenic 
70% ethanol 1 Inhibited NO production Cai & Cai, 2011 
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acid C 
Sarcodon scabrosus (Fr.), P. 
Karst. 
Japan Cyathane diterpenoid Methanol 4 Suppressed TPA-induced 
inflammation 
Hirota et al., 2002 
 Japan Diterpenoid Methanol 4 Suppressed TPA-induced 
inflammation 
Kamo et al., 2004 
1- Nitric oxide assay; 2- Cytokine enzyme linked immunosorbent assay (ELISA); 3- COX-1- and COX-2-Catalyzed Prostaglandin Biosynthesis Assay in Vitro; 4- TPA (12-O-
tetradecanoylphorbol-13-acetate) induced ear edema; 5- Carrageenin-induced paw edema.   
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Table 4. Phenolic compounds and derivatives isolated from mushrooms with reported anti-inflammatory potential. 
Mushroom Origin Bioactive compound Extraction solvent Assay Mechanism of action Reference 
Agaricus bisporus J.E.Lange  Japan 2-Amino-3H-
phenoxazin-3-one 
Ethyl acetate 1,2 3 Inhibited NO, COX1 and COX 2 
activity and cytokine release 
Kohno et al., 2008 
Albatrellus caeruleoporus 
(Peck) Pouzar  
Japan Grifolin dervatives Methanol 1 Reduced NO production  
 
Quang et al., 2006b 
Antrodia camphorata (M.Zang 
& C.H.Su) Sheng H.Wu, 
Ryvarden & T.T.Chang 
Taiwan Benzenoids Ethylacetate, 
methanol 
1 Inhibited NO production Chen et al., 2013 
 Taiwan Antrocamphin A 
(Benzenoids) 
95% Ethanol, ethyl 
acetate, water 
1, 2 Inhibited NO production, Down-
regulated iNOS 
and COX-2 expression 
Hsieh et al., 2010 
 Taiwan Antrocamphin A and 
its analogue 
n.m  Inhibited NO production Lee et al., 2011 
 Taiwan Benzocamphorin Ethanol  1 Inhibited NO production Liao et al., 2012 
Daedalea quercina (L.) Pers. Germany Quercinol n.m 2 Inhibited COX 2 enzyme activity 
 
Gebhardt et al., 2007 
Daldinia childiae Ces. & De 
Not. 
Japan Benzophenone 
derivatives 
n.m 1 Supressed NO production Quang et al., 2006a 
Elaphomyces granulatus Fr. USA Syringaldehyde 
and syringic acid 
95% Ethanol 2 Inhibited COX-2 activity  
 
Stanikunaite et al., 2009 
Grifola gargal Singer Japan Ergothioneine hot water 3 Inhibited TNF-α-induced IL-6 
release 
Ito et al., 2011 
Inonotus xeranticus  (Berk.) 
Imazeki & Aoshima 
Korea Davallialactone n.m 1, 3 Inhibited NO production and 
cytokine release 
Lee et al., 2008 
 Korea Davallialactone n.m 3 Inhibition of ICAM-1, COX-2, and 
iNOS expression   
Lee et al., 2011a 
Neolentinus lepideus	(Fr.) 
Redhead & Ginns 
China Benzoquinone, 
cinnamic acid 
derivatives 
Ethyl acetate 1 Inhibited NO production Li et al., 2013 
Phellinus gilvus (Schwein.) Pat Korea protocatechualdehyde Water 1 Inhibited NO production, inhibited 
iNOS, COX-2 expression 
Chang et al., 2011b 
Phellinus linteus (Berk. & M. 
A. Curtis) Teng 
Taiwan Inotilone  95% Ethanol 1,3 4 Inhibited NO, cytokines and MAPK 
Activation; suppressed edema. 
Huang et al., 2012 
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 Taiwan Hispolon n.m 1, 2 Inhibited NO production and 
cytokine release 
Lin et al., 2014 
n.m – not mentioned; 1- Nitric oxide assay; 2- COX-1- and COX-2-Catalyzed Prostaglandin Biosynthesis Assay in Vitro 3- Cytokine enzyme linked immunosorbent assay (ELISA)  
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Table 5. Common steroids isolated from mushrooms with reported anti-inflammatory activity. 
Mushroom 
 
Origin Bioactive 
compound 
Extraction 
solvent 
Assay Mechanism of  
action 
Reference 
Antrodia camphorata (M.Zang & 
C.H.Su) Sheng H.Wu, Ryvarden 
& T.T.Chang 
Taiwan Ergostatrien-3β-ol Methanol, 
ethyl 
acetate 
1, 2, 3 Decreased IL-1β and TNF-α release; 
inhibited NO and reduced edema 
Huang et al., 2010 
 Taiwan Zhankuic acid C n.m 2 Decreased TNF-α, IL-6, IL-12 Lin et al., 2015 
 Taiwan Zhankuic acid A n.m 2 Inhibited TNF-α and IL-6 levels, inhibits 
iNOS, COX2 expression 
Chen et al., 2014 
Cordyceps militaris (L.) Fr. Taiwan Ergosterol  
 
Methanol 1, 2 Inhibited NO production, decreased 
cytokine release 
Rao et al., 2010 
Ganoderma lucidum (Curtis) P. 
Karst 
India Ergosta-7,22-diene-3β-
yl pentadecanoate 
Petroleum 
ether, 
chloroform 
3 Suppressed edema Joseph et al., 2011 
Grifola frondosa (Dicks.) Gray Taiwan Ergosterol peroxide n-hexane 2 Inhibited IL-1β, IL-6 and TNF-α Wu et al., 2013 
Hericium erinaceum	(Bull.) 
Persoon 
Korea Hericirine (ergosterol) Methanol 1, 2 Inhibited NO production and cytokine 
release 
Li et al., 2014 
 Korea Ergostane-type sterol Methanol 1, 2 Inhibited NO production and release of 
TNF-α 
Li et al., 2015  
Inonotus obliquus (Ach. ex Pers.) 
Pilát 
China Ergosterol, ergosterol 
peroxide, trametenolic 
acid 
Ethanol 1 Inhibited NO production Ma et al., 2013 
Pleurotus tuber-regium (Rumph. 
ex Fr.) Singer 
Belgiu
m 
Cerevisterol, ergosta 
4,6,8(14),22-tetraen-3-
one 
95% 
Ethanol 
1, 2 Inhibited NO and TNF-α, iNOS,COX2 
expression  was inhibited 
 
Liu et al., 2014 
Sarcodon aspratus (Berk.) Japan Ergosterol, ergosterol 
peroxide, 9,11-dehydro 
ergosterol peroxide 
Acetone 2 Decreased TNF-α level, reduced NF-kB 
activity 
Kobori et al., 2007 
n.m- not mentioned; 1- Nitric oxide assay; 2- Cytokine enzyme linked immunosorbent assay (ELISA); 3- Carrageenin-induced paw edema test. 
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Table 6. Other compounds isolated from mushrooms with reported anti-inflammatory activity. 
Mushroom 
 
Origin Bioactive compound Extraction 
solvent 
Assay Mechanism of action Reference 
Agrocybe aegerita (V. Brig.) 
Singer 
USA Fatty acids Methanol 1 Inhibited COX-II enzyme activity Zhang et al., 2003 
Antrodia camphorata (M.Zang & 
C.H.Su) Sheng H.Wu, Ryvarden & 
T.T.Chang 
Taiwan Succinic and  
maleic derivatives 
Methanol 3 Decreased IL-1β and TNF-α release 
 
Chien et al., 2008 
Antrodia cinnamomea Chang & 
Chou 
China Maleimide and Maleic 
Anhydride 
Methanol 2 Inhibited NO production Wu et al., 2008 
 Taiwan Maleimide Derivatives 95% Ethanol  2 Inhibited NO production Wu et al., 2013b 
 Taiwan Antrodan (glycoprotein) Double-
distilled water 
2 Inhibited NO production Chiu et al., 2014 
Coprinus comatus (O.F.Müll.) Pers China Triglycerides Acetone 3 TNF-α, IL-1β Inhibition Ren et al., 2012 
Cordyceps cicadae Taiwan N6-(2-
Hydroxyethyl)adenosine
cordycepin, adenosine 
Ethanol 3 Inhibited production of cytokines Lu et al., 2015  
Cordyceps militaris 
(L.) Fr. 
Korea Cordycepin n.m 2, 3 Inhibited NO production and cytokine 
release  
Jeong et al., 2010 
 Taiwan Cordycepin Methanol 2, 3 Inhibited NO production; Decreased 
cytokine release 
Rao et al., 2010 
 Korea Cordycepin, α-
Dimorphecolic acid 
70% ethanol 2, 3 Inhibited NO and PGE2 production Yoon et al., 2015 
Cordyceps sinensis (Berk.) Sacc. China cordymin Water 3, 5 Decreased IL-1β and TNF-α level, 
inhibition of acetic acid-induced 
constriction 
Qian et al., 2012 
Fomes fomentarius 
(L.) Fr. 
Korea Methyl 9-Oxo-
(10E,12E)-
octadecadienoate 
Methanol 2, 3 Decreased  iNOS expression; Inhibited 
TNF- α production 
Choe et al., 2015 
Ganoderma capense (Lloyd) Teng China Glycopeptide n.m 2 Inhibited NO production Zhou et al., 2014 
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Grifola frondosa 
(Dicks.) Gray 
China Agaricoglycerides Ethyl acetate, 
acetone 
3 Decreased IL-1β and TNF-α;  
inhibited ICAM-1, iNOS, and COX-2 
expression 
Han et al., 2012 
 USA Fatty acid fraction Hexane, ethyl 
acetate, 
methanol 
1 Inhibited COX1 and COX 2 enzyme 
activity 
 
Zhang et al., 2002 
Lignosus rhinocerotis 
(Cooke) Ryvarden 
Malaysia Polysaccharide- 
Protein complexes 
Hot, cold 
Methanol 
3,  
4 
Inhibited TNF- α production; reduced 
carrageenin-induced edema 
Lau et al., 2015 
Pleurotus citrinopileatus Singer Taiwan Nonlectin glycoprotein n.m 2,3 Inhibited NO and PGE2 Chen et al., 2011 
n.m- not mentioned; 1- COX-1- and COX-2-catalyzed prostaglandin biosynthesis assay in vitro; 2- Nitric oxide assay; 3- Cytokine enzyme linked immunosorbent assay (ELISA); 4- 
Carrageenin-induced paw edema  test; 5- Acetic acid induced inflammation test 
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Table 7. Synthesised and commercial compounds with reported anti-inflammatory activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1-Nitric oxide assay; 2- Cytokine enzyme linked immunosorbent assay (ELISA); 3- Carrageenin-induced paw edema test. 
Compounds 
 
Type  Assay Mechanism of action Refrences 
Cinnamic acid, p-hydroxybenzoic acid, p-coumaric acid Commercial 1 Inhibited NO production Taofiq et al., 2015 
Glucuronated p-coumaric acid, methylated p-coumaric acid Synthesised  1 Inhibited NO production Taofiq et al., 2015 
Glucuronated  cinnamic acid, methylated cinnamic acid Synthesised 1 Inhibited NO production Taofiq et al., 2015 
Methylated p-hydroxybenzoic acid, glucuronated p-
hydroxybenzoic acid 
Synthesised 1 Inhibited NO production Taofiq et al., 2015 
Cordycepin Commercial 1, 2 Reduced NO, TNF-α and IL-1β,  
suppressed phosphorylation of 
MAPKs 
Choi et al., 2014b 
 Commercial 1 Reduced NO production Imamura et al., 2015 
 Commercial 1,2  Inhibited NO production and 
cytokine release  
Jeong et al., 2010 
 Commercial 1, 2 Inhibited NO production, 
decreased IL-1β, IL-6, TNF-α 
release 
Shin et al., 2009 
Ethynylbenzenoid Synthesized 2 Down-regulated TNF-α 
expression 
Buccini et al., 2014 
Ergosterol Commercial  Inhibited NO production and 
cytokine release 
Kuo et al., 2011 
Hispidin Commercial 2 Suppressed NF-𝜿B activity, 
induced I𝜅B degradation Shao et al., 2015 
Hispolon Synthesized 1, 2, 3 Inhibited NO production, TNF-α 
release; reduced edema 
Chang et al., 2011a 
 Commercial 1 Inhibition of NO production and 
iNOS expression 
Yang et al 2014 
Inotilone and methylinotilone Synthesized 1, 2 Decreased  nitrite and 
prostaglandin level 
Kuo et al., 2009 
